Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Moonshot to Cancer Cure: Recruiting Policy to Break Down Silos.

Simon M, Cordova E, McKoy JM.

Cancer Treat Res. 2019;171:119-128. doi: 10.1007/978-3-319-43896-2_9.

PMID:
30552661
2.

Cancer Drug Toxicity: Moving from Patient to Survivor.

Slocum M, Garcia SF, McKoy JM.

Cancer Treat Res. 2019;171:107-118. doi: 10.1007/978-3-319-43896-2_8.

PMID:
30552660
3.

Anatomy of Risk Evaluation and Mitigation Strategies (REMS).

Loeser KK, McKoy JM, Schumock GT.

Cancer Treat Res. 2019;171:93-105. doi: 10.1007/978-3-319-43896-2_7. Review.

PMID:
30552659
4.

Biosimilars: Are They Really Safe?

McKoy JM, Giles FJ.

Cancer Treat Res. 2019;171:61-73. doi: 10.1007/978-3-319-43896-2_5.

PMID:
30552657
5.

Pharmacovigilance of Alternative Medications in the Cancer Setting.

Liebling DB, Cordova E, Deng G, McKoy JM.

Cancer Treat Res. 2019;171:37-45. doi: 10.1007/978-3-319-43896-2_3.

PMID:
30552655
6.

Cancer Comorbidity: Implications for Drug Safety.

O'Brien K, McKoy JM, Penedo F.

Cancer Treat Res. 2019;171:21-35. doi: 10.1007/978-3-319-43896-2_2.

PMID:
30552654
7.

Sepsis in Older Adults.

Rowe TA, McKoy JM.

Infect Dis Clin North Am. 2017 Dec;31(4):731-742. doi: 10.1016/j.idc.2017.07.010. Review.

PMID:
29079157
8.

Malnutrition in older patients with cancer: Appraisal of the Mini Nutritional Assessment, weight loss, and body mass index.

Zhang X, Sun M, McKoy JM, Bhulani NNA, Valero V, Barcenas CH, Popat UR, Sri MK, Shah JB, Dinney CP, Hedberg AM, Champlin R, Tripathy D, Holmes HM, Stroehlein JR, Edwards BJ.

J Geriatr Oncol. 2018 Jan;9(1):81-83. doi: 10.1016/j.jgo.2017.07.012. Epub 2017 Aug 24. No abstract available.

PMID:
28844850
9.

NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.

VanderWalde N, Jagsi R, Dotan E, Baumgartner J, Browner IS, Burhenn P, Cohen HJ, Edil BH, Edwards B, Extermann M, Ganti AK, Gross C, Hubbard J, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O'Connor T, Rugo HS, Rupper RW, Shepard D, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Wildes T, Bergman MA, Sundar H, Hurria A.

J Natl Compr Canc Netw. 2016 Nov;14(11):1357-1370.

PMID:
27799507
10.

Survivorship care planning in a comprehensive cancer center using an implementation framework.

Garcia SF, Kircher SM, Oden M, Veneruso A, McKoy JM, Pearman T, Penedo FJ.

J Community Support Oncol. 2016 May;14(5):192-9. doi: 10.12788/jcso.0255.

PMID:
27258051
11.

Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system.

Arabyat RM, Raisch DW, McKoy JM, Bennett CL.

Expert Opin Drug Saf. 2015;14(11):1653-60. doi: 10.1517/14740338.2015.1085968. Epub 2015 Sep 22.

PMID:
26393387
12.

Elevated incidence of fractures in women with invasive breast cancer.

Edwards BJ, Gradishar WJ, Smith ME, Pacheco JA, Holbrook J, McKoy JM, Nardone B, Tica S, Godinez-Puig V, Rademaker AW, Helenowski IB, Bunta AD, Stern PH, Rosen ST, West DP, Guise TA.

Osteoporos Int. 2016 Feb;27(2):499-507. doi: 10.1007/s00198-015-3246-3. Epub 2015 Aug 21.

PMID:
26294292
13.

Economics of Malignant Gliomas: A Critical Review.

Raizer JJ, Fitzner KA, Jacobs DI, Bennett CL, Liebling DB, Luu TH, Trifilio SM, Grimm SA, Fisher MJ, Haleem MS, Ray PS, McKoy JM, DeBoer R, Tulas KM, Deeb M, McKoy JM.

J Oncol Pract. 2015 Jan;11(1):e59-65. doi: 10.1200/JOP.2012.000560. Epub 2014 Dec 2.

14.

Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.

Edwards BJ, Laumann AE, Nardone B, Miller FH, Restaino J, Raisch DW, McKoy JM, Hammel JA, Bhatt K, Bauer K, Samaras AT, Fisher MJ, Bull C, Saddleton E, Belknap SM, Thomsen HS, Kanal E, Cowper SE, Abu Alfa AK, West DP.

Br J Radiol. 2014 Oct;87(1042):20140307. doi: 10.1259/bjr.20140307.

15.

Improving diversity in cancer research trials: the story of the Cancer Disparities Research Network.

Simon MA, de la Riva EE, Bergan R, Norbeck C, McKoy JM, Kulesza P, Dong X, Schink J, Fleisher L.

J Cancer Educ. 2014 Jun;29(2):366-74. doi: 10.1007/s13187-014-0617-y.

16.

Assessing cognitive function and capacity in older adults with cancer.

McKoy JM, Burhenn PS, Browner IS, Loeser KL, Tulas KM, Oden MR, Rupper RW.

J Natl Compr Canc Netw. 2014 Jan;12(1):138-44.

PMID:
24453297
17.

Senior adult oncology, version 2.2014: clinical practice guidelines in oncology .

Hurria A, Wildes T, Blair SL, Browner IS, Cohen HJ, Deshazo M, Dotan E, Edil BH, Extermann M, Ganti AK, Holmes HM, Jagsi R, Karlekar MB, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O'Connor T, Rugo HS, Rupper RW, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Weir AB 3rd, Bergman MA, Sundar H.

J Natl Compr Canc Netw. 2014 Jan;12(1):82-126.

PMID:
24453295
18.

Costs and outcomes evaluation of patient navigation after abnormal cancer screening: evidence from the Patient Navigation Research Program.

Bensink ME, Ramsey SD, Battaglia T, Fiscella K, Hurd TC, McKoy JM, Patierno SR, Raich PC, Seiber EE, Warren-Mears V, Whitley E, Paskett ED, Mandelblatt S; Patient Navigation Research Program.

Cancer. 2014 Feb 15;120(4):570-8. doi: 10.1002/cncr.28438. Epub 2013 Oct 25.

19.

Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report.

Nardone B, Saddleton E, Laumann AE, Edwards BJ, Raisch DW, McKoy JM, Belknap SM, Bull C, Haryani A, Cowper SE, Abu-Alfa AK, Miller FH, Godinez-Puig V, Dharnidharka VR, West DP.

Pediatr Radiol. 2014 Feb;44(2):173-80. doi: 10.1007/s00247-013-2795-x. Epub 2013 Sep 21.

20.

Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's Adverse Event Reporting System and review of case reports in the literature.

Raisch DW, Garg V, Arabyat R, Shen X, Edwards BJ, Miller FH, McKoy JM, Nardone B, West DP.

Expert Opin Drug Saf. 2014 Jan;13(1):15-23. doi: 10.1517/14740338.2013.832752. Epub 2013 Sep 20. Review.

PMID:
24053773
21.

Reporting of serious adverse events during cancer clinical trials to the institutional review board: an evaluation by the research on adverse drug events and reports (RADAR) project.

Belknap SM, Georgopoulos CH, Lagman J, Weitzman SA, Qualkenbush L, Yarnold PR, Edwards BJ, McKoy JM, Trifilio SM, West DP.

J Clin Pharmacol. 2013 Dec;53(12):1334-40. doi: 10.1002/jcph.177. Epub 2013 Sep 25.

PMID:
24030903
22.

Navigating veterans with an abnormal prostate cancer screening test: a quasi-experimental study.

Simon MA, Nonzee NJ, McKoy JM, Liu D, Luu TH, Byer P, Eklund EA, Richey EA, Wu Z, Dong X, Rademaker AW.

BMC Health Serv Res. 2013 Aug 15;13:314. doi: 10.1186/1472-6963-13-314.

23.

Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) project.

Edwards BJ, Usmani S, Raisch DW, McKoy JM, Samaras AT, Belknap SM, Trifilio SM, Hahr A, Bunta AD, Abu-Alfa A, Langman CB, Rosen ST, West DP.

J Oncol Pract. 2013 Mar;9(2):101-6. doi: 10.1200/JOP.2011.000486.

24.

A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report.

Chen B, Restaino J, Norris L, Xirasagar S, Qureshi ZP, McKoy JM, Lopez IS, Trenery A, Murday A, Kahn A, Mattison DR, Ray P, Sartor O, Bennett CL.

J Oncol Pract. 2012 Nov;8(6):e158-67. doi: 10.1200/JOP.2011.000504. Epub 2012 Aug 14.

25.

Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) project.

McKoy JM, Fisher MJ, Courtney DM, Raisch DW, Edwards BJ, Scheetz MH, Belknap SM, Trifilio SM, Samaras AT, Liebling DB, Nardone B, Tulas KM, West DP.

Drug Saf. 2013 May;36(5):335-47. doi: 10.1007/s40264-013-0042-x. Review.

26.

Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR).

Bennett CL, Jacob S, Dunn BL, Georgantopoulos P, Zheng XL, Kwaan HC, McKoy JM, Magwood JS, Qureshi ZP, Bandarenko N, Winters JL, Raife TJ, Carey PM, Sarode R, Kiss JE, Danielson C, Ortel TL, Clark WF, Ablin RJ, Rock G, Matsumoto M, Fujimura Y.

Br J Haematol. 2013 Jun;161(6):896-8. doi: 10.1111/bjh.12303. Epub 2013 Mar 27. No abstract available.

27.

Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs.

Garg V, Raisch DW, McKoy JM, Trifilio SM, Holbrook J, Edwards BJ, Belknap SM, Samaras AT, Nardone B, West DP.

Expert Opin Drug Saf. 2013 May;12(3):299-307. doi: 10.1517/14740338.2013.780024. Epub 2013 Mar 12.

PMID:
23480866
28.

Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.

Edwards BJ, Bunta AD, Lane J, Odvina C, Rao DS, Raisch DW, McKoy JM, Omar I, Belknap SM, Garg V, Hahr AJ, Samaras AT, Fisher MJ, West DP, Langman CB, Stern PH.

J Bone Joint Surg Am. 2013 Feb 20;95(4):297-307. doi: 10.2106/JBJS.K.01181. Review.

29.

Reducing the risks of diabetes complications through diabetes self-management education and support.

Kent D, D'Eramo Melkus G, Stuart PM, McKoy JM, Urbanski P, Boren SA, Coke L, Winters JE, Horsley NL, Sherr D, Lipman R.

Popul Health Manag. 2013 Apr;16(2):74-81. doi: 10.1089/pop.2012.0020. Epub 2013 Feb 13.

PMID:
23405872
30.

Effects of cancer comorbidity on disease management: making the case for diabetes education (a report from the SOAR program).

Irizarry L, Li QE, Duncan I, Thurston AL, Fitzner KA, Edwards BJ, McKoy-Bent JM, Tulas KM, McKoy JM.

Popul Health Manag. 2013 Feb;16(1):53-7. doi: 10.1089/pop.2012.0028. Epub 2012 Oct 31.

31.

Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR).

Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, Raife TJ, Carey PM, Sarode R, Kiss JE, Danielson C, Ortel TL, Clark WF, Rock G, Matsumoto M, Fujimura Y, Zheng XL, Chen H, Chen F, Armstrong JM, Raisch DW, Bennett CL.

Semin Thromb Hemost. 2012 Nov;38(8):845-53. doi: 10.1055/s-0032-1328894. Epub 2012 Oct 30. Review.

32.

Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States.

Qureshi ZP, Norris L, Sartor O, McKoy JM, Armstrong J, Raisch DW, Garg V, Stafkey-Mailey D, Bennett CL.

J Oncol Pract. 2012 Mar;8(2):84-90. doi: 10.1200/JOP.2011.000325. Epub 2011 Dec 13.

33.

Design of a prostate cancer patient navigation intervention for a Veterans Affairs hospital.

Nonzee NJ, McKoy JM, Rademaker AW, Byer P, Luu TH, Liu D, Richey EA, Samaras AT, Panucci G, Dong X, Simon MA.

BMC Health Serv Res. 2012 Sep 25;12:340. doi: 10.1186/1472-6963-12-340.

34.

Temporal lobe epilepsy masquerading as dementia.

Thurston AL, Tulas KM, McKoy JM.

J Am Geriatr Soc. 2012 Aug;60(8):1579-80. doi: 10.1111/j.1532-5415.2012.04089.x. No abstract available.

PMID:
22889023
35.

Comparison of the sensitivity of a pre-MRI questionnaire and point of care eGFR testing for detection of impaired renal function.

Chang P, Saddleton E, Laumann AE, Schmitz B, West DP, Belknap SM, Parthasarathy S, Edwards BJ, McKoy JM, Miller FH.

Acad Radiol. 2012 Oct;19(10):1181-5. doi: 10.1016/j.acra.2012.04.016. Epub 2012 Jul 24.

36.

Amiodarone-associated optic neuropathy: a critical review.

Passman RS, Bennett CL, Purpura JM, Kapur R, Johnson LN, Raisch DW, West DP, Edwards BJ, Belknap SM, Liebling DB, Fisher MJ, Samaras AT, Jones LG, Tulas KM, McKoy JM.

Am J Med. 2012 May;125(5):447-53. doi: 10.1016/j.amjmed.2011.09.020. Epub 2012 Mar 3. Review.

37.

A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era.

Evens AM, Helenowski I, Ramsdale E, Nabhan C, Karmali R, Hanson B, Parsons B, Smith S, Larsen A, McKoy JM, Jovanovic B, Gregory S, Gordon LI, Smith SM.

Blood. 2012 Jan 19;119(3):692-5. doi: 10.1182/blood-2011-09-378414. Epub 2011 Nov 23.

PMID:
22117038
38.

Anticancer drug use in geriatric patients: concerns and challenges.

Lau DT, Jarzebowski MH, McKoy JM.

Clin Ther. 2011 Oct;33(10):1408-12. doi: 10.1016/j.clinthera.2011.07.004. No abstract available.

PMID:
22036129
39.

Psychometric development and reliability analysis of a patient satisfaction with interpersonal relationship with navigator measure: a multi-site patient navigation research program study.

Jean-Pierre P, Fiscella K, Winters PC, Post D, Wells KJ, McKoy JM, Battaglia T, Simon MA, Kilbourn K; Patient Navigation Research Program Group.

Psychooncology. 2012 Sep;21(9):986-92. doi: 10.1002/pon.2002. Epub 2011 Jun 17.

40.

Cancer therapy associated bone loss: implications for hip fractures in mid-life women with breast cancer.

Edwards BJ, Raisch DW, Shankaran V, McKoy JM, Gradishar W, Bunta AD, Samaras AT, Boyle SN, Bennett CL, West DP, Guise TA.

Clin Cancer Res. 2011 Feb 1;17(3):560-8. doi: 10.1158/1078-0432.CCR-10-1595.

41.

Reassessments of ESAs for cancer treatment in the US and Europe.

Bennett CL, McKoy JM, Henke M, Silver SM, MacDougall IC, BirgegÄrd G, Luminari S, Casadevall N, Schellekens H, Sartor O, Lai SY, Armitage JO.

Oncology (Williston Park). 2010 Mar;24(3):260-8.

42.

Racial variations in care and outcomes for inpatient HIV-related pneumocystis pneumonia.

Parada JP, Yarnold PR, Uphold CR, Chmiel JS, DeHovitz JA, Goetz MB, Weinstein RA, McKoy JM, Chandler KL, Bennett CL.

J Health Care Poor Underserved. 2010 Feb;21(1):318-33. doi: 10.1353/hpu.0.0249.

PMID:
20173272
43.

Evaluation of a potential clinical interaction between ceftriaxone and calcium.

Steadman E, Raisch DW, Bennett CL, Esterly JS, Becker T, Postelnick M, McKoy JM, Trifilio S, Yarnold PR, Scheetz MH.

Antimicrob Agents Chemother. 2010 Apr;54(4):1534-40. doi: 10.1128/AAC.01111-09. Epub 2010 Jan 19.

44.

Sildenafil- and tadalafil-associated optic neuropathy: implications for men after prostate cancer treatment.

McKoy JM, Bolden CR, Samaras A, Raisch DW, Chandler K, Bennett CL.

Community Oncol. 2009 Feb 1;6(2):78-80. No abstract available.

45.

Adverse drug interactions: moving from perception to action.

Mayhew R, McKoy JM, Ha Luu T, Lopez I, Frick M, Bennett CL.

Pharmacoeconomics. 2010;28(1):19-22. doi: 10.2165/11530370-000000000-00000. No abstract available.

PMID:
20014873
46.

Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening.

Shankaran V, Luu TH, Nonzee N, Richey E, McKoy JM, Graff Zivin J, Ashford A, Lantigua R, Frucht H, Scoppettone M, Bennett CL, Sheinfeld Gorin S.

J Clin Oncol. 2009 Nov 10;27(32):5370-5. doi: 10.1200/JCO.2008.20.6458. Epub 2009 Oct 13.

47.

Evaluating the cost-effectiveness of cancer patient navigation programs: conceptual and practical issues.

Ramsey S, Whitley E, Mears VW, McKoy JM, Everhart RM, Caswell RJ, Fiscella K, Hurd TC, Battaglia T, Mandelblatt J; Patient Navigation Research Program Group.

Cancer. 2009 Dec 1;115(23):5394-403. doi: 10.1002/cncr.24603. Review.

48.

Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?

Richey EA, Lyons EA, Nebeker JR, Shankaran V, McKoy JM, Luu TH, Nonzee N, Trifilio S, Sartor O, Benson AB 3rd, Carson KR, Edwards BJ, Gilchrist-Scott D, Kuzel TM, Raisch DW, Tallman MS, West DP, Hirschfeld S, Grillo-Lopez AJ, Bennett CL.

J Clin Oncol. 2009 Sep 10;27(26):4398-405. doi: 10.1200/JCO.2008.21.1961. Epub 2009 Jul 27.

49.

Upping recruitment in clinical trials: are the costs worth it?

McKoy JM, Samaras AT, Luu TH, Bennett CL.

Onkologie. 2009 Jul;32(7):378-9. doi: 10.1159/000223742. Epub 2009 Jun 20. No abstract available.

50.

Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate.

Dorr DA, Burdon R, West DP, Lagman J, Georgopoulos C, Belknap SM, McKoy JM, Djulbegovic B, Edwards BJ, Weitzman SA, Boyle S, Tallman MS, Talpaz M, Sartor O, Bennett CL.

Clin Cancer Res. 2009 Jun 1;15(11):3850-5. doi: 10.1158/1078-0432.CCR-08-1811. Epub 2009 May 19.

Supplemental Content

Loading ...
Support Center